HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seok-Ho Kim Selected Research

tirandamycin B

1/2020Asparaginyl-tRNA Synthetase, a Novel Component of Hippo Signaling, Binds to Salvador and Enhances Yorkie-Mediated Tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seok-Ho Kim Research Topics

Disease

11Neoplasms (Cancer)
01/2020 - 10/2009
4Infections
12/2022 - 01/2010
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021 - 05/2020
2Metabolic Diseases (Metabolic Disease)
02/2019 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 12/2016
1Bacterial Infections (Bacterial Infection)
12/2022
1Malaria
12/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Neuroblastoma
01/2021
1Carcinogenesis
01/2020
1Epilepsy (Aura)
02/2019
1Body Weight (Weight, Body)
01/2019
1Pathologic Constriction (Stenosis)
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Teratoma (Teratoid Tumor)
01/2019
1Pathologic Neovascularization
10/2018
1Blindness (Hysterical Blindness)
10/2018
1Obesity
07/2018
1Autoimmune Diseases (Autoimmune Disease)
06/2018
1Inflammation (Inflammations)
01/2018
1Colitis
01/2018
1Neoplasm Metastasis (Metastasis)
06/2015
1Hypoxia (Hypoxemia)
01/2014
1Hemolytic Anemia
05/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
10/2007
1Ischemic Stroke
10/2007
1Wounds and Injuries (Trauma)
10/2007
1Myocardial Infarction
10/2007
1Infarction (Infarctions)
10/2007
1Acute Erythroblastic Leukemia (Erythroleukemia)
08/2007

Drug/Important Bio-Agent (IBA)

3Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022 - 01/2010
3Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2010
3Neoplasm Antigens (Tumor Antigens)IBA
07/2014 - 10/2009
2Pharmaceutical PreparationsIBA
12/2022 - 07/2010
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2018
2Biological ProductsIBA
02/2019 - 01/2018
2AntigensIBA
07/2014 - 10/2009
1artemisinin (artemisinine)IBA
12/2022
1CopperIBA
12/2022
1LigandsIBA
01/2022
1corniculatolide BIBA
11/2021
1Messenger RNA (mRNA)IBA
01/2021
1TropomyosinIBA
01/2021
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021
1trkB ReceptorIBA
01/2021
1Ligases (Synthetase)IBA
01/2020
1asparaginyl-tRNA synthetaseIBA
01/2020
1tirandamycin BIBA
01/2020
1Transfer RNA (tRNA)IBA
01/2020
1HydantoinsIBA
02/2019
1sepantroniumIBA
01/2019
1SurvivinIBA
01/2019
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018
1Cytidine Triphosphate (CTP)IBA
07/2018
1LipidsIBA
07/2018
1CytokinesIBA
06/2018
1Interleukin-1beta (Interleukin 1 beta)IBA
06/2018
1Dextran SulfateIBA
01/2018
1Chalcone (Benzalacetophenone)IBA
01/2018
1CarbonIBA
01/2018
1xanthohumolIBA
01/2018
1esculetinIBA
01/2017
1AntioxidantsIBA
01/2017
1kahweolIBA
12/2016
1DiterpenesIBA
12/2016
1Small Interfering RNA (siRNA)IBA
06/2015
1Matrix Metalloproteinases (MMPs)IBA
06/2015
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
07/2014
1RotenoneIBA
01/2014
1antimycinIBA
01/2014
1mito-carboxy proxylIBA
01/2014
1Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2013
1Cathepsin BIBA
06/2013
1ChalconesIBA
06/2013
1Cancer VaccinesIBA
11/2010
1NADPH Oxidases (NAD(P)H oxidase)IBA
01/2010
1VaccinesIBA
10/2009
1PeroxiredoxinsIBA
05/2008
1Therapeutic UsesIBA
10/2007
1QuinolonesIBA
10/2007
1Peroxiredoxin IIIIBA
08/2007
1Peroxidase (Myeloperoxidase)IBA
08/2007

Therapy/Procedure

2Therapeutics
05/2020 - 07/2010
2Immunotherapy
07/2014 - 10/2009
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2019